|
US4816567A
(en)
|
1983-04-08 |
1989-03-28 |
Genentech, Inc. |
Recombinant immunoglobin preparations
|
|
US5807715A
(en)
|
1984-08-27 |
1998-09-15 |
The Board Of Trustees Of The Leland Stanford Junior University |
Methods and transformed mammalian lymphocyte cells for producing functional antigen-binding protein including chimeric immunoglobulin
|
|
US5427908A
(en)
|
1990-05-01 |
1995-06-27 |
Affymax Technologies N.V. |
Recombinant library screening methods
|
|
EP0519596B1
(en)
|
1991-05-17 |
2005-02-23 |
Merck & Co. Inc. |
A method for reducing the immunogenicity of antibody variable domains
|
|
WO1994004679A1
(en)
|
1991-06-14 |
1994-03-03 |
Genentech, Inc. |
Method for making humanized antibodies
|
|
GB9115364D0
(en)
|
1991-07-16 |
1991-08-28 |
Wellcome Found |
Antibody
|
|
AU669124B2
(en)
|
1991-09-18 |
1996-05-30 |
Kyowa Hakko Kirin Co., Ltd. |
Process for producing humanized chimera antibody
|
|
ES2136092T3
(es)
|
1991-09-23 |
1999-11-16 |
Medical Res Council |
Procedimientos para la produccion de anticuerpos humanizados.
|
|
US5733743A
(en)
|
1992-03-24 |
1998-03-31 |
Cambridge Antibody Technology Limited |
Methods for producing members of specific binding pairs
|
|
US6180377B1
(en)
|
1993-06-16 |
2001-01-30 |
Celltech Therapeutics Limited |
Humanized antibodies
|
|
US6265150B1
(en)
|
1995-06-07 |
2001-07-24 |
Becton Dickinson & Company |
Phage antibodies
|
|
WO1998023289A1
(en)
|
1996-11-27 |
1998-06-04 |
The General Hospital Corporation |
MODULATION OF IgG BINDING TO FcRn
|
|
US6277375B1
(en)
|
1997-03-03 |
2001-08-21 |
Board Of Regents, The University Of Texas System |
Immunoglobulin-like domains with increased half-lives
|
|
HUP0204475A2
(en)
|
2000-02-11 |
2003-04-28 |
Merck Patent Gmbh |
Enhancing the circulating half-life of antibody-based fusion proteins
|
|
US20030091568A1
(en)
|
2000-04-07 |
2003-05-15 |
Jurgen Frey |
Inhibitors for the formation of soluble human CD23
|
|
EP1142910A1
(en)
|
2000-04-07 |
2001-10-10 |
Jürgen Prof. Dr. Frey |
Inhibitors for the formation of soluble human CD23
|
|
PT1355919E
(pt)
|
2000-12-12 |
2011-03-02 |
Medimmune Llc |
Moléculas com semivida longa, composições que as contêm e suas utilizações
|
|
AU2002347182A1
(en)
|
2001-12-18 |
2003-06-30 |
Mondobiotech Licensing Out Ag |
Pharmaceutical composition of interferon gamma or pirfenidone with molecular diagnostics for the improved treatment of interstitial lung diseases
|
|
US6716821B2
(en)
|
2001-12-21 |
2004-04-06 |
Immunogen Inc. |
Cytotoxic agents bearing a reactive polyethylene glycol moiety, cytotoxic conjugates comprising polyethylene glycol linking groups, and methods of making and using the same
|
|
US20040092466A1
(en)
|
2002-11-11 |
2004-05-13 |
Isis Pharmaceuticals Inc. |
Modulation of ADAM9 expression
|
|
JP2006500364A
(ja)
|
2002-08-16 |
2006-01-05 |
イムノージェン インコーポレーテッド |
高い反応性と溶解度を有する架橋剤および小分子薬物の標的化送達用コンジュゲートの調製におけるそれらの使用
|
|
US7217797B2
(en)
|
2002-10-15 |
2007-05-15 |
Pdl Biopharma, Inc. |
Alteration of FcRn binding affinities or serum half-lives of antibodies by mutagenesis
|
|
US8088387B2
(en)
|
2003-10-10 |
2012-01-03 |
Immunogen Inc. |
Method of targeting specific cell populations using cell-binding agent maytansinoid conjugates linked via a non-cleavable linker, said conjugates, and methods of making said conjugates
|
|
DE10337368A1
(de)
*
|
2003-08-08 |
2005-03-03 |
Technische Universität Dresden |
Verfahren und Mittel zur Diagnose und Behandlung von Pankreastumoren
|
|
WO2005047327A2
(en)
|
2003-11-12 |
2005-05-26 |
Biogen Idec Ma Inc. |
NEONATAL Fc RECEPTOR (FcRn)-BINDING POLYPEPTIDE VARIANTS, DIMERIC Fc BINDING PROTEINS AND METHODS RELATED THERETO
|
|
WO2005091823A2
(en)
|
2004-03-01 |
2005-10-06 |
The Regents Of The University Of California |
The use of lunasin peptide as a transcriptional activator to prevent cancer and related methods for treatment, monitoring and prognosis
|
|
US8802820B2
(en)
|
2004-11-12 |
2014-08-12 |
Xencor, Inc. |
Fc variants with altered binding to FcRn
|
|
US8367805B2
(en)
|
2004-11-12 |
2013-02-05 |
Xencor, Inc. |
Fc variants with altered binding to FcRn
|
|
AU2006210589B2
(en)
|
2005-02-02 |
2011-12-08 |
Macrogenics West, Inc. |
ADAM-9 modulators
|
|
US8445198B2
(en)
|
2005-12-01 |
2013-05-21 |
Medical Prognosis Institute |
Methods, kits and devices for identifying biomarkers of treatment response and use thereof to predict treatment efficacy
|
|
ES2567402T3
(es)
|
2006-05-30 |
2016-04-22 |
Genentech, Inc. |
Anticuerpos anti CD22, sus inmunoconjugados y usos de los mismos
|
|
WO2007143752A2
(en)
|
2006-06-09 |
2007-12-13 |
The Regents Of The University Of California |
Targets in breast cancer for prognosis or therapy
|
|
KR101443214B1
(ko)
|
2007-01-09 |
2014-09-24 |
삼성전자주식회사 |
폐암 환자 또는 폐암 치료를 받은 폐암 환자의 폐암 재발 위험을 진단하기 위한 조성물, 키트 및 마이크로어레이
|
|
GB2453589A
(en)
|
2007-10-12 |
2009-04-15 |
King S College London |
Protease inhibition
|
|
GB0724357D0
(en)
*
|
2007-12-14 |
2008-01-23 |
Glaxosmithkline Biolog Sa |
Method for preparing protein conjugates
|
|
WO2009114532A2
(en)
|
2008-03-10 |
2009-09-17 |
National Jewish Health |
Markers for diagnosis of pulmonary inflammation and methods related thereto
|
|
AU2009233899A1
(en)
|
2008-04-07 |
2009-10-15 |
Zymogenetics, Inc. |
Thrombin activator compostions and methods of making and using the same
|
|
US20090285840A1
(en)
*
|
2008-04-29 |
2009-11-19 |
New York Society For The Ruptured And Crippled Maintaining The Hospital For Special Surgery |
Methods for treating pathological neovascularization
|
|
KR20200058590A
(ko)
|
2008-04-30 |
2020-05-27 |
이뮤노젠 아이엔씨 |
가교제 및 그 용도
|
|
EP2276506A4
(en)
|
2008-04-30 |
2014-05-07 |
Immunogen Inc |
EFFICIENT CONJUGATES AND HYDROPHILIC BINDER
|
|
ES2675730T3
(es)
|
2008-06-04 |
2018-07-12 |
Macrogenics, Inc. |
Anticuerpos con unión alterada a FcRn y métodos de uso de los mismos
|
|
US20110129450A1
(en)
|
2008-08-01 |
2011-06-02 |
Orly Lazarov |
Method of promoting neurogenesis by modulating secretase activities
|
|
WO2010053539A2
(en)
|
2008-11-05 |
2010-05-14 |
The Texas A&M University System |
Methods for detecting colorectal diseases and disorders
|
|
MX2011005953A
(es)
|
2008-12-04 |
2011-08-17 |
Abbott Lab |
Inmunoglobulinas de dominio variable dual y usos de las mismas.
|
|
EP2486023A4
(en)
*
|
2009-10-06 |
2014-05-07 |
Immunogen Inc |
EFFICIENT CONJUGATES AND HYDROPHILIC BINDER
|
|
WO2011050180A1
(en)
*
|
2009-10-21 |
2011-04-28 |
Immunogen, Inc. |
Novel dosing regimen and method of treatment
|
|
WO2011100362A1
(en)
|
2010-02-11 |
2011-08-18 |
University Of Southern California |
Modified adam disintegrin domain polypeptides and uses thereof
|
|
JP5998060B2
(ja)
|
2010-03-04 |
2016-09-28 |
マクロジェニクス，インコーポレーテッド |
Ｂ７−ｈ３と反応性のある抗体、その免疫学的に活性なフラグメントおよびその使用
|
|
US20130058947A1
(en)
|
2011-09-02 |
2013-03-07 |
Stem Centrx, Inc |
Novel Modulators and Methods of Use
|
|
WO2013049704A2
(en)
|
2011-09-28 |
2013-04-04 |
Armune Biosciences, Inc. |
Method and system of particle-phage epitope complex
|
|
WO2013098797A2
(en)
|
2011-12-31 |
2013-07-04 |
Kuriakose Moni Abraham |
Diagnostic tests for predicting prognosis, recurrence, resistance or sensitivity to therapy and metastatic status in cancer
|
|
US9534058B2
(en)
|
2012-02-08 |
2017-01-03 |
Abbvie Stemcentrx Llc |
Anti-CD324 monoclonal antibodies and uses thereof
|
|
EP2943585B1
(en)
|
2013-01-09 |
2018-07-11 |
Friedrich-Alexander-Universität Erlangen-Nürnberg |
Method for in vitro detection and monitoring of a disease by measuring disease-associated protease activity in extracellular vesicles
|
|
US10047163B2
(en)
|
2013-02-08 |
2018-08-14 |
Abbvie Stemcentrx Llc |
Multispecific constructs
|
|
MX379256B
(es)
*
|
2013-03-15 |
2025-03-10 |
Regeneron Pharma |
Moleculas biologicamente activas, conjugados de las mismas, y usos terapeuticos.
|
|
JPWO2014168154A1
(ja)
|
2013-04-08 |
2017-02-16 |
三菱レイヨン株式会社 |
眼疾患を評価するためのマイクロアレイ及び眼疾患の評価方法
|
|
EP2996721B1
(en)
|
2013-05-13 |
2021-10-06 |
Tufts University |
Compositions for treatment of adam8-expressing cancer
|
|
EP3011050B1
(en)
|
2013-06-19 |
2017-09-06 |
Memorial Sloan Kettering Cancer Center |
Methods and compositions for the diagnosis, prognosis and treatment of brain metastasis
|
|
US9567641B2
(en)
|
2013-07-03 |
2017-02-14 |
Samsung Electronics Co., Ltd. |
Combination therapy for the treatment of cancer using an anti-C-met antibody
|
|
MX2017006016A
(es)
|
2014-11-11 |
2017-06-19 |
Amunix Operating Inc |
Composiciones conjugadas de xten direccionadas y metodos para producir las mismas.
|
|
SG11201806478PA
(en)
*
|
2016-02-05 |
2018-08-30 |
Immunogen Inc |
Efficient process for preparing cell-binding agent-cytotoxic agent conjugates
|
|
SI3558391T1
(sl)
*
|
2016-12-23 |
2022-06-30 |
Immunogen, Inc. |
Imunokonjugati, ciljno usmerjeni na ADAM9, in načini njihove uporabe
|